Literature DB >> 28039496

FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future.

Abass Alavi1, Thomas J Werner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28039496     DOI： 10.1007/s00259-016-3606-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  27 in total

Review 1.  Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.

Authors:  Mariza Vorster; Mike M Sathekge; Jamshed Bomanji
Journal:  Curr Opin Pulm Med       Date:  2014-05       Impact factor: 3.155

2.  Cancer or inflammation? A Holy Grail for nuclear medicine.

Authors:  S M Larson
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

3.  PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.

Authors:  Ray Y Chen; Lori E Dodd; Myungsun Lee; Praveen Paripati; Dima A Hammoud; James M Mountz; Doosoo Jeon; Nadeem Zia; Homeira Zahiri; M Teresa Coleman; Matthew W Carroll; Jong Doo Lee; Yeon Joo Jeong; Peter Herscovitch; Saher Lahouar; Michael Tartakovsky; Alexander Rosenthal; Sandeep Somaiyya; Soyoung Lee; Lisa C Goldfeder; Ying Cai; Laura E Via; Seung-Kyu Park; Sang-Nae Cho; Clifton E Barry
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

Review 4.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

Review 5.  Whole-body FDG-PET imaging in the management of patients with cancer.

Authors:  Roland Hustinx; François Bénard; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

6.  Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.

Authors:  S Basu; J Kung; M Houseni; H Zhuang; G F Tidmarsh; A Alavi
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-03-12       Impact factor: 2.346

7.  (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.

Authors:  V Martinez; M A Castilla-Lievre; C Guillet-Caruba; G Grenier; R Fior; S Desarnaud; F Doucet-Populaire; F Boué
Journal:  Int J Tuberc Lung Dis       Date:  2012-07-12       Impact factor: 2.373

Review 8.  Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades.

Authors:  A Alavi; L J Hirsch
Journal:  Semin Nucl Med       Date:  1991-01       Impact factor: 4.446

9.  Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.

Authors:  Andréluís Branco de Barros; Andrew Tsourkas; Babak Saboury; Valbert Nascimento Cardoso; Abass Alavi
Journal:  EJNMMI Res       Date:  2012-07-18       Impact factor: 3.138

Review 10.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21
View more
  4 in total

Review 1.  Nuclear and Optical Bimodal Imaging Probes Using Sequential Assembly: A Perspective.

Authors:  Shin Hye Ahn; Eszter Boros
Journal:  Cancer Biother Radiopharm       Date:  2018-07-13       Impact factor: 3.099

2.  Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis.

Authors:  Abass Alavi; Sean D Carlin; Thomas J Werner; Abdullah Al-Zaghal
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

3.  FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future.

Authors:  Abdullah Al-Zaghal; William Y Raynor; Siavash Mehdizadeh Seraj; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01       Impact factor: 9.236

4.  Linear Desferrichrome-Linked Silicon-Rhodamine Antibody Conjugate Enables Targeted Multimodal Imaging of HER2 in Vitro and in Vivo.

Authors:  Shin Hye Ahn; Daniel Thach; Brett A Vaughn; Vincent M Alford; Alyssa N Preston; Scott T Laughlin; Eszter Boros
Journal:  Mol Pharm       Date:  2019-02-15       Impact factor: 4.939
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.